These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Detection of a novel point mutation in the p53 gene in grade II astrocytomas by PCR-SSCP analysis with additional Klenow treatment. Chawengchao B; Petmitr S; Ponglikitmongkol M; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W Anticancer Res; 2001; 21(4A):2739-43. PubMed ID: 11724349 [TBL] [Abstract][Full Text] [Related]
5. Genetic evidence of the neoplastic nature of gemistocytes in astrocytomas. Reis RM; Hara A; Kleihues P; Ohgaki H Acta Neuropathol; 2001 Nov; 102(5):422-5. PubMed ID: 11699553 [TBL] [Abstract][Full Text] [Related]
6. Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas. Cheng Y; Pang JC; Ng HK; Ding M; Zhang SF; Zheng J; Liu DG; Poon WS Histopathology; 2000 Nov; 37(5):437-44. PubMed ID: 11119125 [TBL] [Abstract][Full Text] [Related]
8. Role of gemistocytes in astrocytoma progression. Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164 [TBL] [Abstract][Full Text] [Related]
9. Immunocytochemical mapping of the phosphatase and tensin homolog (PTEN/MMAC1) tumor suppressor protein in human gliomas. Fults D; Pedone C Neuro Oncol; 2000 Apr; 2(2):71-9. PubMed ID: 11303623 [TBL] [Abstract][Full Text] [Related]
10. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter. Fujisawa H; Kurrer M; Reis RM; Yonekawa Y; Kleihues P; Ohgaki H Am J Pathol; 1999 Aug; 155(2):387-94. PubMed ID: 10433932 [TBL] [Abstract][Full Text] [Related]
11. PTEN protein expression correlates with PTEN gene molecular changes but not with VEGF expression in astrocytomas. Idoate MA; Soria E; Lozano MD; Sola JJ; Panizo A; de Alava E; Manrique M; Pardo-Mindán FJ Diagn Mol Pathol; 2003 Sep; 12(3):160-5. PubMed ID: 12960698 [TBL] [Abstract][Full Text] [Related]
12. Alterations of the RRAS and ERCC1 genes at 19q13 in gemistocytic astrocytomas. Ohta T; Kim YH; Oh JE; Satomi K; Nonoguchi N; Keyvani K; Pierscianek D; Sure U; Mittelbronn M; Paulus W; Vital A; Yokoo H; McDonald K; Kleihues P; Nazaret N; Barbet F; Lachuer J; Ohgaki H J Neuropathol Exp Neurol; 2014 Oct; 73(10):908-15. PubMed ID: 25192052 [TBL] [Abstract][Full Text] [Related]
13. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression. Nozaki M; Tada M; Kobayashi H; Zhang CL; Sawamura Y; Abe H; Ishii N; Van Meir EG Neuro Oncol; 1999 Apr; 1(2):124-37. PubMed ID: 11550308 [TBL] [Abstract][Full Text] [Related]
14. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255 [TBL] [Abstract][Full Text] [Related]
15. Timing of p53 mutations during astrocytoma tumorigenesis. del Arco A; García J; Arribas C; Barrio R; Blázquez MG; Izquierdo JM; Izquierdo M Hum Mol Genet; 1993 Oct; 2(10):1687-90. PubMed ID: 8268922 [TBL] [Abstract][Full Text] [Related]
16. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies. Watanabe K; Sato K; Biernat W; Tachibana O; von Ammon K; Ogata N; Yonekawa Y; Kleihues P; Ohgaki H Clin Cancer Res; 1997 Apr; 3(4):523-30. PubMed ID: 9815715 [TBL] [Abstract][Full Text] [Related]
17. [Fraction of gemistocytic astrocytes and immunoexpression of p53 protein in astrocytomas grade II and III (WHO)]. Martins DC; Stávale JN; Malheiros SM; Santiago LH; Roman LC; Aguiar KC Arq Neuropsiquiatr; 2001 Dec; 59(4):926-31. PubMed ID: 11733839 [TBL] [Abstract][Full Text] [Related]
18. p53 gene mutations in human astrocytic brain tumors including pilocytic astrocytomas. Patt S; Gries H; Giraldo M; Cervos-Navarro J; Martin H; Jänisch W; Brockmöller J Hum Pathol; 1996 Jun; 27(6):586-9. PubMed ID: 8666369 [TBL] [Abstract][Full Text] [Related]
19. Molecular genetic alterations in glioblastomas with oligodendroglial component. Kraus JA; Lamszus K; Glesmann N; Beck M; Wolter M; Sabel M; Krex D; Klockgether T; Reifenberger G; Schlegel U Acta Neuropathol; 2001 Apr; 101(4):311-20. PubMed ID: 11355302 [TBL] [Abstract][Full Text] [Related]
20. PTEN, DMBT1, and p16 alterations in diffusely infiltrating astrocytomas. Fan X; Muñoz J; Sanko SG; Castresana JS Int J Oncol; 2002 Sep; 21(3):667-74. PubMed ID: 12168116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]